Observational studyClinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology2026

Early and Sustained Asthma Control and Remission in Real-World Patients With Severe Eosinophilic Asthma Treated With Benralizumab: XALOC-2.

Erika Penz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.